The veterinary services market would grow at a CAGR of 9.8% over the predicted time frame. The market is expected to increase in value from US$ 114.41 Bn in 2022 to US$ 241.76 Bn in 2030.
The on veterinary services Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.
Download Free Sample@ https://www.precedenceresearch.com/sample/2393
A recent report provides crucial insights along with application based and forecast information in the Global Veterinary services Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Veterinary services market.
A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.
Companies and Manufacturers Covered
The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Veterinary services market are included as given below:
Veterinary services Market Key Players
- Merck Animal Health
- Ceva Sante Animale
- Vetoquinol S.A.
- Zoetis
- Boehringer Ingelheim GmbH
- Elanco
- Nutreco N.V.
- Virbac
- Kindred Biosciences, Inc.
- Biogenesis Bago
- Indian Immunologicals Ltd.
- Neogen Corp.
- Hester Biosciences
- Phibro Animal Health
- Dechra Pharmaceuticals PL
Market Segments
By Service Type
- Diagnostic tests and imaging
- Physical health monitoring
- Surgery
- Others
By Animal Type
- Production
- Poultry
- Swine
- Cattle
- Sheep & Goats
- Fish
- Companion
- Dogs
- Cats
- Horses
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
Report Objectives
- To define, describe, and forecast the global veterinary services market based on product, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the veterinary services market
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Veterinary Services Market
5.1. COVID-19 Landscape: Veterinary Services Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Veterinary Services Market, By Service Type
8.1. Veterinary Services Market, by Service Type, 2022-2030
8.1.1. Diagnostic tests and imaging
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Physical health monitoring
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Surgery
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Dessert
8.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Veterinary Services Market, By Animal Type
9.1. Veterinary Services Market, by Animal Type, 2022-2030
9.1.1. Production
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Poultry
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Swine
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Cattle
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Sheep & Goats
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Fish
9.1.6.1. Market Revenue and Forecast (2017-2030)
9.1.7. Companion
9.1.7.1. Market Revenue and Forecast (2017-2030)
9.1.8. Dogs
9.1.8.1. Market Revenue and Forecast (2017-2030)
9.1.9. Cats
9.1.9.1. Market Revenue and Forecast (2017-2030)
9.1.10. Horses
9.1.10.1. Market Revenue and Forecast (2017-2030)
9.1.11. Others
9.1.11.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Veterinary Services Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Service Type (2017-2030)
10.1.2. Market Revenue and Forecast, by Animal Type (2017-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Service Type (2017-2030)
10.1.3.2. Market Revenue and Forecast, by Animal Type (2017-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Service Type (2017-2030)
10.1.4.2. Market Revenue and Forecast, by Animal Type (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Service Type (2017-2030)
10.2.2. Market Revenue and Forecast, by Animal Type (2017-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Service Type (2017-2030)
10.2.3.2. Market Revenue and Forecast, by Animal Type (2017-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Service Type (2017-2030)
10.2.4.2. Market Revenue and Forecast, by Animal Type (2017-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Service Type (2017-2030)
10.2.5.2. Market Revenue and Forecast, by Animal Type (2017-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Service Type (2017-2030)
10.2.6.2. Market Revenue and Forecast, by Animal Type (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Service Type (2017-2030)
10.3.2. Market Revenue and Forecast, by Animal Type (2017-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Service Type (2017-2030)
10.3.3.2. Market Revenue and Forecast, by Animal Type (2017-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Service Type (2017-2030)
10.3.4.2. Market Revenue and Forecast, by Animal Type (2017-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Service Type (2017-2030)
10.3.5.2. Market Revenue and Forecast, by Animal Type (2017-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Service Type (2017-2030)
10.3.6.2. Market Revenue and Forecast, by Animal Type (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Service Type (2017-2030)
10.4.2. Market Revenue and Forecast, by Animal Type (2017-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Service Type (2017-2030)
10.4.3.2. Market Revenue and Forecast, by Animal Type (2017-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Service Type (2017-2030)
10.4.4.2. Market Revenue and Forecast, by Animal Type (2017-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Service Type (2017-2030)
10.4.5.2. Market Revenue and Forecast, by Animal Type (2017-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Service Type (2017-2030)
10.4.6.2. Market Revenue and Forecast, by Animal Type (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Service Type (2017-2030)
10.5.2. Market Revenue and Forecast, by Animal Type (2017-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Service Type (2017-2030)
10.5.3.2. Market Revenue and Forecast, by Animal Type (2017-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Service Type (2017-2030)
10.5.4.2. Market Revenue and Forecast, by Animal Type (2017-2030)
Chapter 11. Company Profiles
11.1. Merck Animal Health
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Ceva Sante Animale
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Vetoquinol S.A.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Zoetis
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Boehringer Ingelheim GmbH
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Elanco
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Nutreco N.V.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Virbac
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Kindred Biosciences, Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Biogenesis Bago
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
0 Comments